To study the effect of tumor-derived IL-6 on the differentiation of myeloid progenitors, IL-6R-blocking antibody (IL-6R Ab) was applied to inhibit IL-6 signal transduction and the activation of the JAK/STAT3 signaling pathway. The gene discussed is STAT3; the disease is neoplasm.